ATE509933T1 - Pentacyclische kinaseinhibitoren - Google Patents

Pentacyclische kinaseinhibitoren

Info

Publication number
ATE509933T1
ATE509933T1 AT06813425T AT06813425T ATE509933T1 AT E509933 T1 ATE509933 T1 AT E509933T1 AT 06813425 T AT06813425 T AT 06813425T AT 06813425 T AT06813425 T AT 06813425T AT E509933 T1 ATE509933 T1 AT E509933T1
Authority
AT
Austria
Prior art keywords
kinase inhibitors
pentacyclic
malignancies
compounds
useful
Prior art date
Application number
AT06813425T
Other languages
English (en)
Inventor
Thomas Rawson
Brian Safina
Jennafer Dotson
Ignacio Aliagas-Martin
Jason Halladay
Jun Liang
Matthias Rueth
Bing-Yan Zhu
Frederick Brookfield
Michael Prime
Birong Zhang
Jun Li
Aihe Zhou
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE509933T1 publication Critical patent/ATE509933T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT06813425T 2005-08-12 2006-08-14 Pentacyclische kinaseinhibitoren ATE509933T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70790205P 2005-08-12 2005-08-12
PCT/US2006/031682 WO2007022102A2 (en) 2005-08-12 2006-08-14 Pentacyclic kinase inhibitors

Publications (1)

Publication Number Publication Date
ATE509933T1 true ATE509933T1 (de) 2011-06-15

Family

ID=37607426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06813425T ATE509933T1 (de) 2005-08-12 2006-08-14 Pentacyclische kinaseinhibitoren

Country Status (14)

Country Link
US (1) US7749994B2 (de)
EP (1) EP1919920B1 (de)
JP (1) JP2009504680A (de)
KR (1) KR20080035691A (de)
CN (1) CN101287737A (de)
AT (1) ATE509933T1 (de)
AU (1) AU2006279659A1 (de)
BR (1) BRPI0615141A2 (de)
CA (1) CA2619276A1 (de)
IL (1) IL189296A0 (de)
NO (1) NO20081292L (de)
RU (1) RU2008108903A (de)
WO (1) WO2007022102A2 (de)
ZA (1) ZA200801332B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8716308B2 (en) * 2008-01-11 2014-05-06 Albany Molecular Research, Inc. (1-azinone)-substituted pyridoindoles
WO2011003005A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en) * 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US9073925B2 (en) * 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
EP2887804B1 (de) 2012-05-22 2021-01-27 Trustees of Dartmouth College Cycloalkanyl[b]indolen zur verwendung als glp-1 modulatoren
WO2017162661A1 (en) 2016-03-22 2017-09-28 Bayer Pharma Aktiengesellschaft 1h-benzo[de]isoquinoline-1,3(2h)-diones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032869A1 (en) 2003-07-08 2005-02-10 Pharmacia Italia S.P.A. Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2006133885A1 (en) * 2005-06-15 2006-12-21 F. Hoffmann-La Roche Ag Tricyclic fused indole derivatives and their use as aurora kinase inhibitors

Also Published As

Publication number Publication date
ZA200801332B (en) 2009-10-28
RU2008108903A (ru) 2009-09-20
CA2619276A1 (en) 2007-02-22
KR20080035691A (ko) 2008-04-23
EP1919920A2 (de) 2008-05-14
BRPI0615141A2 (pt) 2009-07-14
EP1919920B1 (de) 2011-05-18
US20070037791A1 (en) 2007-02-15
JP2009504680A (ja) 2009-02-05
US7749994B2 (en) 2010-07-06
WO2007022102A3 (en) 2007-05-10
NO20081292L (no) 2008-05-13
IL189296A0 (en) 2008-06-05
WO2007022102A2 (en) 2007-02-22
CN101287737A (zh) 2008-10-15
AU2006279659A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
NO20073783L (no) Pyrrolidininhibitorer for IAP
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
NO20081292L (no) Pentasykliske kinaseinhibitorer
TW200800999A (en) Novel compounds
MX2009014247A (es) Compuestos heterociclicos utiles como inhibidores de mk2.
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
SE0302811D0 (sv) Novel compounds
CY1113192T1 (el) Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου μεσω αναστολης της κινασης aurora
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
ATE479687T1 (de) Kinaseinhibitoren
MX2007005932A (es) 1-alquinil-2-ariloxialquilamidas y su uso como fungicidas.
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
NO20071127L (no) Triazoloftalaziner
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
UA107689C2 (xx) ПОХІДНІ 3,4,4A,10B-ТЕТРАГІДРО-1H-ТІОПІРАНО$4, 3-c]ІЗОХІНОЛІНУ
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
EA200801199A1 (ru) Ингибиторы киназы
WO2007120333A3 (en) Tetracyclic kinase inhibitors
SE0301650D0 (sv) Novel compounds
MX2008001538A (es) Aril piridinas y metodos para su uso.
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
UA85505C2 (en) Kinase inhibitors
MX2010010876A (es) Piperidinas sustituidas como compuestos terapeuticos.
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties